… ovarian cancer, ovarian signalling pathway, ovarian cancer diagnosis and prognosis, and
current and/or new ovarian cancer biomarkers, … In Section 2.1, Ovarian Cancer Cell Signalling …

… We have identified a novel biomarker, mammaglobin-2 (MGB2), which is highly expressed
specific to ovarian cancer. MGB2, in combination with other putative markers identified here, …

… role in the development of ovarian cancer and how it may be used as a predictive and
targetable biomarker. MUTYH mutations may confer the risk of ovarian cancer by the failure of its …

… include transvaginal ultrasonography, biomarker analysis, or … robust biomarkers for early
detection of ovarian cancer and … predictive biomarkers for the clinical management of ovarian …

… biomarkers in ovarian cancer, we analysed blood samples from women diagnosed with ovarian
cancer, … For example, the use of circulating miRNAs as biomarkers of cancer have come …

… We investigated this question by analysing the predictive value for time to cancer progression
for each individual biomarker. The results of the Cox analyses are summarised in Table 4. …

… an ovarian cancer–specific predictive framework for clinical stage, histotype, residual
tumor burden, and prognosis using machine learning methods based on multiple biomarkers. …

… One of the major challenges in establishing prognostic and predictive biomarkers in ovarian
cancer is the heterogeneity associated with clinicopathological and molecular levels of the …

… ovarian cancer–for virtually all of the major cancers, many promising predictive biomarkers
… evaluate the performance of biomarkers for early detection of ovarian cancer using a nested …

… lack of specific symptoms and effective biomarkers for an early detection. Currently, cancer
antigen 125 (CA125) is the most widely used biomarker for ovarian cancer detection, but this …